| Literature DB >> 34564136 |
Tatyana O Mizgina1,2, Irina V Chikalovets1,2, Valentina I Molchanova1, Rustam H Ziganshin3, Oleg V Chernikov1.
Abstract
Lectin from the bivalve Glycymeris yessoensis (GYL) was purified by affinity chromatography on porcine stomach mucin-Sepharose. GYL is a dimeric protein with a molecular mass of 36 kDa, as established by SDS-PAGE and MALDI-TOF analysis, consisting of 18 kDa subunits linked by a disulfide bridge. According to circular dichroism data, GYL is a β/α-protein with the predominance of β-structure. GYL preferentially agglutinates enzyme-treated rabbit erythrocytes and recognizes glycoproteins containing O-glycosidically linked glycans, such as porcine stomach mucin (PSM), fetuin, thyroglobulin, and ovalbumin. The amino acid sequences of five segments of GYL were acquired via mass spectrometry. The sequences have no homology with other known lectins. GYL is Ca2+-dependent and stable over a range above a pH of 8 and temperatures up to 20 °C for 30 min. GYL is a pattern recognition receptor, as it binds common pathogen-associated molecular patterns, such as peptidoglycan, LPS, β-1,3-glucan and mannan. GYL possesses a broad microbial-binding spectrum, including Gram-positive (Bacillus subtilis, Staphylococcus aureus) and Gram-negative bacteria (Escherichia coli, Vibrio proteolyticus), but not the fungus Candida albicans. Expression levels of GYL in the hemolymph were significantly upregulated after bacterial challenge by V. proteolyticus plus environmental stress (diesel fuel). Results indicate that GYL is probably a new member of the C-type lectin family, and may be involved in the immune response of G. yessoensis to bacterial attack.Entities:
Keywords: bivalve lectins; hemolymph; microorganism binding; pattern recognition receptors
Mesh:
Substances:
Year: 2021 PMID: 34564136 PMCID: PMC8466245 DOI: 10.3390/md19090474
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Purification of Glycymeris yessoensis lectin (GYL): Cell-free hemolymph (plasma) was used for affinity chromatography on a PSM–Sepharose column (2.0 × 5.0 cm) that had previously been equilibrated with 0.01 M TBS–Ca (0.01 M Tris-HCl, 0.15 M NaCl, 0.01 M CaCl2, pH 8.0). The elution was performed with glycine–HCl buffer, pH 2.9 (indicated by the arrow); pH was then neutralized with 1 M Tris. The elution profile (solid line) shows plasma protein (optical density at 280 nm) and agglutinating activity (titer) toward trypsin-treated rabbit erythrocytes (dotted line). A major peak and hemagglutination activity titer maximum were observed at fractions 23–35.
Purification of lectin from the hemolymph of the of the mollusk G. yessoensis.
| Sample | Volume (mL) | Titer HA | Total Activity a | Protein Concentration (mg/mL) | Protein Amount (mg) | Specific Activity b | Purification Ratio (fold) c | Recovery of Activity (%) d |
|---|---|---|---|---|---|---|---|---|
| Crude hemolymph | 50 | 512 | 25,600 | 11.75 | 587.50 | 43.57 | 1 | 100 |
| Purified lectin | 2 | 2048 | 4096 | 0.63 | 1.26 | 3250.79 | 74.61 | 16 |
a Total activity is calculated as titer × volume; b Specific activity is calculated as titer/mg of protein; c Purification ratio is calculated by comparing the value of specific activity of the crude extract vs. purified lectin; d Recovery of activity is calculated by comparing the value of total activity of the crude extract vs. purified lectin.
Figure 2(a) SDS-PAGE of GYL. Protein bands were stained with Coomassie Brilliant Blue R-250 reagent. Lanes: M: molecular weight markers (kDa); 1: GYL in non-reducing conditions (without DTT); 2: GYL in reducing conditions (with DTT). (b) Molecular mass determination of GYL via MALDI-TOF mass spectrometry. (c) Size exclusion chromatography of GYL on Superdex 75.
Agglutination of erythrocytes by GYL.
| Type of Erythrocytes | Titer of Agglutination | |
|---|---|---|
| Untrypsinized | Trypsinized | |
| Human O | 128 | 256 |
| Human A | 16 | 16 |
| Human B | 16 | 16 |
| Human AB | 32 | 128 |
| Rabbit | 128 | 512 |
| Mouse | 8 | 32 |
Specificity of GYL for carbohydrates and glycoproteins.
| Inhibitor | Concentration at Half-Maximal Inhibition of Binding |
|---|---|
| L-Fucose | 0.17 mM (0.028 mg/mL) |
| PSM | 0.033 mg/mL |
| Asialo-PSM | 0.008 mg/mL |
| Fetuin | 0.008 mg/mL |
| Asialofetuin | 0.004 mg/mL |
| Thyroglobulin | 0.004 mg/mL |
| Ovalbumin | 0.025 mg/mL |
The following substances caused no inhibition when used at 10 mg/mL: D-glucose, N-acetyl-D-glucosamine, D-galactose (Gal), N-acetyl-D-galactosamine (GalNAc), D-mannose, N-acetyl-D-mannosamine, N-acetyl-neuraminic acid, N-acetyl-glycoloylneuraminic acid, p-nitrophenyl-β-D-galactoside, Galα1-3GalNAc, methyl-α-D-galactopyranoside, lactose, melibiose, ovomucoid, α1-acid glycoprotein, and mannan from Saccharomyces cerevisiae.
Figure 3Effects of (a) pH, (b) temperature, and (c) CaCl2 on the hemagglutination activity of GYL.
Components of the secondary structure of GYL.
| Sample | α-Helix | β-Sheet | β-Turn | Random Coil | ||||
|---|---|---|---|---|---|---|---|---|
| I | II | III | I | II | III | |||
| GYL | 0.1 | 4.6 | 4.7 | 28.3 | 13.7 | 42.0 | 20.7 | 32.6 |
Peptide sequences.
| Peptide | z | Mass | |
|---|---|---|---|
| TTASQLENASKNHYWLNGTDSAVEGQFR | 1042.8264 | 3 | 3125.4326 |
| CFSYVDWMSAEEPNDRFDADCLHLR | 1045.1152 | 3 | 3132.3164 |
| WNDLSCSK | 505.2257 | 2 | 1008.4335 |
| LPFFFLCEKPTETCSDK | 1060.0051 | 2 | 2117.98 |
| MTQAAAEEYCTTQDGHLAQPTSEGLNTFLK | 1110.177 | 3 | 3327.5022 |
Figure 4Distribution of GYL in different tissues and hemolymph of G. yessoensis measured by ELISA. Four biological replicates were performed, and the data are shown as mean ± S.D (n = 3).
Figure 5(a) ELLA analysis of the interaction between GYL and various PAMPs. The data are the mean ± SD (n = 3). (b) The microbe binding activity of GYL as revealed by Western blot.
Figure 6Temporal expression levels of GYL in the hemolymph after V. proteolyticus challenge and diesel fuel exposure as measured by ELISA. Vertical bars represent the mean ± SD (n = 3). Significant (p < 0.05) differences from the control are indicated with asterisk.